1 January 2022 false No description of principal activity Taxfiler 2023.10.1 10481180business:PrivateLimitedCompanyLtd2022-01-012022-12-31 104811802021-12-31 104811802022-01-012022-12-31 10481180business:AuditExempt-NoAccountantsReport2022-01-012022-12-31 10481180business:FilletedAccounts2022-01-012022-12-31 104811802022-12-31 10481180business:Director12022-01-012022-12-31 10481180business:Director22022-01-012022-12-31 10481180business:Director32022-01-012022-12-31 10481180business:RegisteredOffice2022-01-012022-12-31 104811802021-12-31 10481180core:WithinOneYear2022-12-31 10481180core:WithinOneYear2021-12-31 10481180core:AfterOneYear2022-12-31 10481180core:AfterOneYear2021-12-31 10481180core:ShareCapitalcore:PreviouslyStatedAmount2022-12-31 10481180core:ShareCapitalcore:PreviouslyStatedAmount2021-12-31 10481180core:SharePremiumcore:PreviouslyStatedAmount2022-12-31 10481180core:SharePremiumcore:PreviouslyStatedAmount2021-12-31 10481180core:RevaluationReservecore:PreviouslyStatedAmount2022-12-31 10481180core:RevaluationReservecore:PreviouslyStatedAmount2021-12-31 10481180core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-12-31 10481180core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2021-12-31 10481180core:PreviouslyStatedAmount2022-12-31 10481180core:PreviouslyStatedAmount2021-12-31 10481180business:SmallEntities2022-01-012022-12-31 10481180countries:EnglandWales2022-01-012022-12-31 10481180core:Goodwill2021-12-31 10481180core:Goodwill2022-12-31 10481180core:AdditionsToInvestments2022-12-31 104811802021-01-012021-12-31 iso4217:GBP xbrli:pure
Company Registration No. 10481180 (England and Wales)
ATLAS BIOMED GROUP LIMITED Unaudited accounts for the year ended 31 December 2022
ATLAS BIOMED GROUP LIMITED Unaudited accounts Contents
Page
- 2 -
ATLAS BIOMED GROUP LIMITED Company Information for the year ended 31 December 2022
Directors
Sergei Musienko Timofey Prokopov Sergey Anoshin
Company Number
10481180 (England and Wales)
Registered Office
INTERCHANGE HOUSE OFFICE 1.58 81-85 STATION ROAD CROYDON CR0 2RD UNITED KINGDOM
- 3 -
ATLAS BIOMED GROUP LIMITED Statement of financial position as at 31 December 2022
2022 
2021 
Notes
£ 
£ 
Fixed assets
Intangible assets
1,359,864 
1,359,864 
Investments
181,256 
1,436 
1,541,120 
1,361,300 
Current assets
Debtors
13,592,717 
11,865,153 
Cash at bank and in hand
154,725 
38,481 
13,747,442 
11,903,634 
Creditors: amounts falling due within one year
(1,095,659)
(660,233)
Net current assets
12,651,783 
11,243,401 
Total assets less current liabilities
14,192,903 
12,604,701 
Creditors: amounts falling due after more than one year
(5,336,466)
(3,399,400)
Net assets
8,856,437 
9,205,301 
Capital and reserves
Called up share capital
240 
240 
Share premium
11,969,293 
11,969,293 
Revaluation reserve
(147,053)
(147,053)
Profit and loss account
(2,966,043)
(2,617,179)
Shareholders' funds
8,856,437 
9,205,301 
For the year ending 31 December 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 27 November 2023 and were signed on its behalf by
Sergei Musienko Director Company Registration No. 10481180
- 4 -
ATLAS BIOMED GROUP LIMITED Notes to the Accounts for the year ended 31 December 2022
1
Statutory information
ATLAS BIOMED GROUP LIMITED is a private company, limited by shares, registered in England and Wales, registration number 10481180. The registered office is INTERCHANGE HOUSE OFFICE 1.58, 81-85 STATION ROAD, CROYDON, CR0 2RD, UNITED KINGDOM.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Intangible fixed assets
Goodwill 
£ 
Cost
At 1 January 2022
2,119,268 
At 31 December 2022
2,119,268 
Amortisation
At 1 January 2022
759,404 
At 31 December 2022
759,404 
Net book value
At 31 December 2022
1,359,864 
At 31 December 2021
1,359,864 
5
Investments
Subsidiary undertakings 
£ 
Valuation at 1 January 2022
1,436 
Additions
179,820 
Valuation at 31 December 2022
181,256 
6
Debtors
2022 
2021 
£ 
£ 
Amounts falling due within one year
Amounts due from group undertakings etc.
13,459,235 
11,825,576 
Other debtors
133,482 
39,577 
13,592,717 
11,865,153 
- 5 -
ATLAS BIOMED GROUP LIMITED Notes to the Accounts for the year ended 31 December 2022
7
Creditors: amounts falling due within one year
2022 
2021 
£ 
£ 
Trade creditors
245,952 
13,619 
Amounts owed to group undertakings and other participating interests
649,577 
646,614 
Taxes and social security
125,404 
- 
Other creditors
74,726 
- 
1,095,659 
660,233 
8
Creditors: amounts falling due after more than one year
2022 
2021 
£ 
£ 
Other creditors
5,336,466 
3,399,400 
9
Average number of employees
During the year the average number of employees was 3 (2021: 2).
- 6 -